Literature DB >> 30668753

TNM classification of gynaecological malignant tumours, eighth edition: changes between the seventh and eighth editions.

Hideki Tokunaga1, Muneaki Shimada1, Mitsuya Ishikawa2, Nobuo Yaegashi1.   

Abstract

The staging classification of gynaecological malignancies has been revised by the International Federation of Gynecology and Obstetrics (FIGO) and has been subsequently reviewed by the FIGO Committee on Gynecologic Oncology, the International Union for Cancer Control TNM Committee and the American Joint Committee on Cancer. The major change in the eighth edition of TNM classification of gynaecological malignant tumours is integrated staging for ovarian, fallopian tube and primary peritoneal carcinoma, whereas the seventh edition distinguished 'ovary and primary peritoneal carcinoma' and 'Fallopian tube carcinoma'. Furthermore, the new edition describes a prognostic factor grid for vulvar, cervical, endometrial and ovarian, fallopian tube and primary peritoneal carcinoma. If these factors contribute strongly to the prognosis, they may be incorporated into future staging classifications. This paper reviews the staging system for gynaecological malignancies, how it was developed, and current problems to be resolved.
© The Author(s) 2019. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  FIGO; TNM; female organs; prognosis

Mesh:

Year:  2019        PMID: 30668753     DOI: 10.1093/jjco/hyy206

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  6 in total

1.  Receptor for activated C kinase 1 promotes cervical cancer lymph node metastasis via the glycolysis‑dependent AKT/mTOR signaling.

Authors:  Lixiu Xu; Jinqiu Li; Mikrban Tursun; Yan Hai; Hatila Tursun; Batur Mamtimin; Ayshamgul Hasim
Journal:  Int J Oncol       Date:  2022-05-26       Impact factor: 5.884

2.  TOP2A/MCM2, p16INK4a, and cyclin E1 expression in liquid-based cytology: a biomarkers panel for progression risk of cervical premalignant lesions.

Authors:  Oscar Del Moral-Hernández; Daniel Hernández-Sotelo; Luz Del Carmen Alarcón-Romero; Miguel Angel Mendoza-Catalán; Eugenia Flores-Alfaro; Yaneth Castro-Coronel; Julio Ortiz-Ortiz; Marco Antonio Leyva-Vázquez; Carlos Ortuño-Pineda; Wendy Castro-Mora; Berenice Illades-Aguiar
Journal:  BMC Cancer       Date:  2021-01-07       Impact factor: 4.430

3.  Preoperative Prognostic Nutritional Index and Neutrophil-to-Lymphocyte Ratio Predict Survival Outcomes of Patients With Hepatocellular Carcinoma After Curative Resection.

Authors:  Zhen Qu; Yun-Jie Lu; Jia-Wei Feng; Yu-Xiang Chen; Long-Qing Shi; Jing Chen; Navin Rambaran; Yun-Fei Duan; Xiao-Zhou He
Journal:  Front Oncol       Date:  2022-01-28       Impact factor: 6.244

4.  Circulating ciRS-7 as a potential non-invasive biomarker for epithelial ovarian cancer: An investigative study.

Authors:  Aferin Beilerli; Sema Begliarzade; Albert Sufianov; Tatiana Ilyasova; Yanchao Liang; Ozal Beylerli
Journal:  Noncoding RNA Res       Date:  2022-07-31

5.  Validation of the prognostic value of various lymph node staging systems for cervical squamous cell carcinoma following radical surgery: a single-center analysis of 3,732 patients.

Authors:  Qinhao Guo; Jun Zhu; Yong Wu; Hao Wen; Lingfang Xia; Xingzhu Ju; Guihao Ke; Xiaohua Wu
Journal:  Ann Transl Med       Date:  2020-04

Review 6.  A multidisciplinary approach remains the best strategy to improve and strengthen the management of ovarian cancer (Review).

Authors:  Luca Falzone; Giuseppa Scandurra; Valentina Lombardo; Giuseppe Gattuso; Alessandro Lavoro; Andrea Benedetto Distefano; Giuseppe Scibilia; Paolo Scollo
Journal:  Int J Oncol       Date:  2021-06-16       Impact factor: 5.650

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.